Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

CEPRATE SC approved for marketing in U.S.

Dec. 12, 1996

Drugs quicker to reach market in U.S. than in Germany and Japan

Dec. 12, 1996

Signal acquires rights to novel signaling proteins

Dec. 11, 1996

GenPharm generates human anti-IL-8 antibodies

Dec. 5, 1996

New patient-activated drug delivery system from Medtronic released in Europe

Dec. 5, 1996

Sterinetics System successfully inactivates multiple viruses in IVIg

Dec. 5, 1996

RTP to accelerate development of insoluble drug delivery technology

Dec. 5, 1996

Incyte and Abbott expand genomic database agreement

Dec. 5, 1996

Patent issued for Vical's core technology

Dec. 5, 1996

Neurochem/Parke-Davis collaboration on antiamyloid compounds

Dec. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...